Real-world (RW) treatment (Tx) patterns and clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC): Results of a nationwide, longitudinal, retrospective study in Hungary

被引：0
作者：
Maraz, A. C. [1 ]
Nagy, B. [2 ]
Macher, T. [2 ]
Jesko, J. [2 ]
Tischler, E. [3 ]
Csongvai, C. [4 ]
Kearney, M. [5 ]
机构：
[1] Univ Szeged, Dept Oncotherapy, Szeged, Hungary
[2] Healthware Consulting Ltd, Budapest, Hungary
[3] Merck Kft, Market Access, Budapest, Hungary
[4] Merck Kft, Med Affairs, Budapest, Hungary
[5] Merck Healthcare KGaA, Global Evidence & Value Dev, Darmstadt, Germany
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1834
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1756P
引用
收藏
页码：S1341 / S1341
页数：1
相关论文
共 50 条
  • [31] Insights into second-line (2L) systemic treatment (tx) receipt in patients (pts) with metastatic urothelial carcinoma (mUC): Results of a retrospective observational study in Germany
    Niegisch, G.
    Kearney, M.
    Krieger, J.
    Osowski, U.
    Deiters, B.
    Maywald, U.
    Wilke, T.
    Grimm, M-O. J.
    ANNALS OF ONCOLOGY, 2024, 35 : S1154 - S1154
  • [32] Treatment patterns and clinical outcomes in patients with metastatic urothelial carcinoma in England: A retrospective observational study.
    Shiri, Tinevimbo
    Nievaart, Max
    Gill, Simran
    Perkin, William
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [33] Real-world survival outcomes and treatment patterns in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Results from the OREIOS study
    Chan, Stephen
    Breder, Valeriy Vladimirovich
    Shao, Yu Yun
    Tai, David
    Waked, Imam
    Ganguly, Sandip
    Alolayan, Ashwaq
    Aboutaleb, Ahmed
    Farag, Heba
    Ryu, Min-Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 449 - 449
  • [34] Real-world outcomes of metastatic urothelial carcinoma (mUC) patients (pts) treated with first or second-line immunotherapies (10) in the United States (US)
    Boyd, Marley
    Annavarapu, Srinivas
    Doshi, Gurjyot K.
    Imai, Kentaro
    Sbar, Eric
    Godwin, James Luke
    Li, Haojie
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Real-World Metastatic Renal Cell Carcinoma Treatment Patterns and Clinical Outcomes in The Netherlands
    van Laar, S. A.
    Gombert-Handoko, K. B.
    Groenwold, R. H. H.
    van der Hulle, T.
    Visser, L. E.
    Houtsma, D.
    Guchelaar, H. J.
    Zwaveling, J.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] Assessment of treatment patterns and real-world outcomes following changes in the treatment paradigm for locally advanced/metastatic urothelial carcinoma (la/mUC) in the US.
    Kirker, Melissa
    Abraham, Anup
    Vlahiotis, Anna
    Bhanegaonkar, Abhijeet
    Benjumea, Darrin
    Kim, Chai
    Sun, Haiyan
    Kearney, Mairead
    Chandrasekar, Sanjana
    Li, Benjamin
    Thakkar, Sheena
    Moon, Helen H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [37] A real-world study of chemotherapy treatment and costs in metastatic urothelial cancer (mUC) patients in the United States
    Malangone-Monaco, Elisabetta
    Wilson, Kathleen
    Varker, Helen
    Stetsovsky, Diana
    Shih-Wen, Lin
    Tayama, Darren
    Ogale, Sarika
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study
    Brandon T. McDaniel
    Victor Cornet
    Jeanne Carroll
    Lambros Chrones
    Joseph Chudzik
    Jeanette Cochran
    Shion Guha
    Debra F. Lawrence
    Maggie McCue
    Sara Sarkey
    Betty Lorenz
    Jay Fawver
    BMC Psychiatry, 23
  • [39] Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study
    McDaniel, Brandon T.
    Cornet, Victor
    Carroll, Jeanne
    Chrones, Lambros
    Chudzik, Joseph
    Cochran, Jeanette
    Guha, Shion
    Lawrence, Debra F.
    McCue, Maggie
    Sarkey, Sara
    Lorenz, Betty
    Fawver, Jay
    BMC PSYCHIATRY, 2023, 23 (01)
  • [40] Effect of neutrophil to lymphocyte ratio (NLR) on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in real-world setting.
    Lynn, David
    Dawsey, Scott
    Patgunarajah, Ubenthira
    Pramod, Nikhil
    Wei, Wei
    Hobeika, Charbel
    Nair, Monica
    Maroli, Kimberly
    Martin, Allison
    Ornstein, Moshe Chaim
    Wee, Christopher Eing
    Gilligan, Timothy D.
    Nizam, Amanda
    Bonham, Amanda
    Mian, Omar Y.
    Pavicic, Paul G.
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 678 - 678
12345